Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Basella alba extract is a preparation derived from the leaves and stems of Basella alba, a fast-growing perennial vine known as Malabar spinach, Indian spinach, or vine spinach. It is rich in phytochemicals including flavonoids, saponins, carotenoids, alkaloids, and various vitamins (A, C). The extract has demonstrated diverse pharmacological activities in both preclinical and in vitro studies—showing anti-inflammatory, antioxidant, neuroprotective, antiulcer, antidiabetic, and wound healing effects. Its mechanisms of action appear to include antioxidant activity (via scavenging of free radicals), inhibition of acetylcholinesterase (enhancing cholinergic neurotransmission and cognitive function), membrane stabilization, and modulation of biological pathways related to oxidative stress and inflammation. Its use is largely as a dietary supplement or traditional medicinal agent for supporting general health, reducing inflammation, aiding gastrointestinal health, and mitigating neurodegenerative processes, though it is not an approved pharmaceutical[1][3][5][7][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on basella alba extract.